Cancer Management and Research
Volume 13, 2021 - Issue
Open access
120
Views
7
CrossRef citations to date
0
Altmetric
Original Research
miRNA-382-5p Suppresses the Expression of Farnesoid X Receptor to Promote Progression of Liver Cancer
Xiaobo Nie1 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, People’s Hospital of Hebi, Henan University, Kaifeng, People’s Republic of China
https://orcid.org/0000-0001-8117-4616
Huiyang Liu1 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, People’s Hospital of Hebi, Henan University, Kaifeng, People’s Republic of China
, Xiaoyun Wei1 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, People’s Hospital of Hebi, Henan University, Kaifeng, People’s Republic of China
, Lanqing Li1 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, People’s Hospital of Hebi, Henan University, Kaifeng, People’s Republic of China
, Linhua Lan2 Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People’s Republic of China
, Lili Fan1 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, People’s Hospital of Hebi, Henan University, Kaifeng, People’s Republic of China
, Han Ma1 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, People’s Hospital of Hebi, Henan University, Kaifeng, People’s Republic of China
, Lei Liu1 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, People’s Hospital of Hebi, Henan University, Kaifeng, People’s Republic of China
, Yun Zhou1 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, People’s Hospital of Hebi, Henan University, Kaifeng, People’s Republic of China
, Ruifang Hou1 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, People’s Hospital of Hebi, Henan University, Kaifeng, People’s Republic of China
& Wei-Dong Chen1 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences, People’s Hospital of Hebi, Henan University, Kaifeng, People’s Republic of China;3 Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, Key Laboratory of Molecular Pathology, School of Basic Medical Science, Inner Mongolia Medical University, Hohhot, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-3386-4492
Pages 8025-8035
|
Published online: 22 Oct 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.